Track Regencell Bioscience Holdings Limited Ordinary Shares — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Regencell Bioscience Holdings Limited Ordinary Shares RGC Open Regencell Bioscience Holdings Limited Ordinary Shares in new tab

30.80 USD
EPS
-0.01
P/B
2567.00
ROE
-54.81
Beta
2.07
Loading chart...
Key Metrics
Earnings dateJune 2, 2026
EPS-0.01
Book Value0.01
Price to Book2567.00
Debt/Equity11.20
% Insiders88.555%

DCF Valuation

Tweak assumptions to recompute fair value for Regencell Bioscience Holdings Limited Ordinary Shares (RGC)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Regencell Bioscience Holdings Limited Ordinary Shares Logo Regencell Bioscience Holdings Limited Ordinary Shares Analysis (RGC)

Hong Kong Health Care Official Website Stock

Is Regencell Bioscience Holdings Limited Ordinary Shares a good investment? Regencell Bioscience Holdings Limited Ordinary Shares (RGC) is currently trading at 30.80 USD.

Earnings Schedule: Regencell Bioscience Holdings Limited Ordinary Shares is expected to release its next earnings report on June 2, 2026.

Investor FAQ

Does Regencell Bioscience Holdings Limited Ordinary Shares pay a dividend?

No, it does not currently pay a dividend.

What asset class is Regencell Bioscience Holdings Limited Ordinary Shares?

Regencell Bioscience Holdings Limited Ordinary Shares is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be June 2, 2026. The company currently has a trailing EPS of -0.01.

Company Profile

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Exchange Ticker
NMS (United States) RGC
Historical Dividends
Year Total Dividends
2018 8.36 USD
2017 33.44 USD
2016 33.44 USD
2015 33.44 USD
2014 33.44 USD
2013 31.92 USD
2012 31.92 USD
2011 31.92 USD
2010 27.36 USD
2009 20.52 USD

Yearly aggregated dividends

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion